Long-term Follow-up Results of CARsgen's Satri-cel as Sequential Therapy After First-Line Treatment for Gastric Cancer Presented at the 2026...
PR Newswire
Today at 12:15am UTC
ASCO 2026 | CStone Presents Updated Clinical Data for CS2009 (PD-1/VEGF/CTLA-4 Trispecific Antibody), Reinforcing Triple-Target Synergy and...
PR Newswire
Today at 12:15am UTC
ImmVira Reports 100% Complete Response Rate at 9 Months in Bladder Carcinoma in Situ with MVR-T3011 at ASCO
PR Newswire
Today at 12:00am UTC
D3 Bio Presents First-Line Data for Elisrasib (D3S-001) at ASCO 2026; Next-Generation KRAS G12C Inhibitor Shows Landmark Efficacy in...
PR Newswire
Today at 12:00am UTC
New Taipei City Showcases Smart Manufacturing Strength at AUTOMATE 2026
PR Newswire
Today at 12:00am UTC
MICROIP to Debut "AI Vehicle System Business Group" and Edge AI Innovations at COMPUTEX 2026
PR Newswire
Today at 12:00am UTC
AMD Bundles Carbice Ice Pad with Ryzen™ 7 5800X3D
PR Newswire
Today at 12:00am UTC
Carbice and Noctua Partner to Bring Advanced Thermal Pad Technology to DIY PC Builders
PR Newswire
Today at 12:00am UTC
2026 ASCO | Innovent Presents Preliminary PoC Data of IBI363 (TAK-928) PD-1/IL-2α-bias bispecific fusion protein) in First-line Advanced...
PR Newswire
Today at 12:00am UTC
2026 ASCO | Innovent Presents Long-Term Follow-up Results from the PoC Study of IBI363 (TAK-928) (PD-1/IL-2α-bias bispecific fusion protein)...
PR Newswire
Today at 12:00am UTC
BriaCell Therapeutics Announces Pricing of Offering
GlobeNewswire
Yesterday at 11:59pm UTC
Self OPEN EMDR: The Honest Pros and Cons of Doing It Without a Therapist
GlobeNewswire
Yesterday at 11:31pm UTC
TiumBio to Present Phase 2a Interim Data Highlighting Differentiated Clinical Profile for Tosposertib(TU2218) plus Pembrolizumab in First...
PR Newswire
Yesterday at 11:30pm UTC
Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026
GlobeNewswire
Yesterday at 11:30pm UTC
Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026
GlobeNewswire
Yesterday at 11:30pm UTC
Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026
GlobeNewswire
Yesterday at 11:30pm UTC
Scripps Pulls 54 Local Stations from DIRECTV After Seeking Record Retransmission Consent Rates
PR Newswire
Yesterday at 11:27pm UTC
ROSEN, LEADING INVESTOR COUNSEL, Encourages Calix, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -...
GlobeNewswire
Yesterday at 11:01pm UTC
Monday, June 1, 2026
PR Newswire
Yesterday at 11:01pm UTC
GOSS Investors Have Opportunity to Lead Gossamer Bio, Inc. Securities Fraud Lawsuit with the Schall Law Firm
GlobeNewswire
Yesterday at 10:59pm UTC